Repros Announces Acceptance of Dossier for Enclomiphene for Secondary Hypogonadism by European Authorities
/
Date05 Oct 2016
THE WOODLANDS, Texas, Oct. 05, 2016 (GLOBE NEWSWIRE) — Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced that it has received confirmation of acceptance of its September... Read More →
CoLucid Pharmaceuticals Announces Additional Analyses of Lasmiditan’s Onset of Action Data from SAMURAI and Supporting Non-Clinical Data
/
Date05 Oct 2016
Lasmiditan (100 mg and 200 mg) oral tablets had onset of action and provided significant headache pain relief as soon as 30 minutes after dosing... Read More →
Workers' Compensation Benefits for Injured Workers Reach Historic Lows
/
Date05 Oct 2016
WASHINGTON, DC, Oct. 5, 2016 (GLOBE NEWSWIRE) — Workers’ compensation benefits as a share of payroll are reaching historically low levels, even as employers shoulder... Read More →
TPP Healthcare to Host China Partnering Forum at Leading MedTech Conference
/
Date05 Oct 2016
NEW YORK, Oct. 05, 2016 (GLOBE NEWSWIRE) — TPP Healthcare, a global advisory firm specializing in deal flows targeting China’s healthcare sector, announces its China... Read More →
CymaBay Therapeutics Announces Plans to Initiate Its Next Phase 2 Study of MBX-8025 in Primary Biliary Cholangitis
/
Date05 Oct 2016
NEWARK, Calif., Oct. 05, 2016 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies to treat metabolic diseases with... Read More →
Collegium Submits Supplemental New Drug Submission to FDA for Xtampza® ER
/
Date05 Oct 2016
CANTON, Mass., Oct. 05, 2016 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced today that it has submitted a Supplemental New Drug Application (sNDA) to... Read More →
Global Diabetes Care Devices Market worth USD 26.0 Billion by 2021: By Device Types, Size, Growth and Major Regions
/
Date05 Oct 2016
Sarasota, FL, Oct. 05, 2016 (GLOBE NEWSWIRE) — Zion Research has published a new report titled “Diabetes Care Devices Market by Glucose Monitoring Device (Blood... Read More →
Griffin-American Healthcare REIT IV Acquires Medical Office Buildings in Michigan and Alabama
/
Date04 Oct 2016
IRVINE, Calif., Oct. 04, 2016 (GLOBE NEWSWIRE) — American Healthcare Investors and Griffin Capital Corporation, the co-sponsors of Griffin-American Healthcare REIT IV, Inc., announced today... Read More →
Cempra Presents Analysis Showing Rates of Failure for Existing CABP Antibiotics From Claims Database at Academy of Managed Care Pharmacy Meeting
/
Date04 Oct 2016
—More than 20 percent of adult CABP patients failed initial antibiotic monotherapy, including approximately one of four elderly patients— —Average U.S. macrolide resistance to S.... Read More →
Summit to Host Conference Call to Discuss Exclusive License and Collaboration Agreement With Sarepta Therapeutics for European Rights to Summit’s Utrophin Modulator Pipeline for the Treatment of Duchenne Muscular Dystrophy
/
Date04 Oct 2016
OXFORD, United Kingdom, Oct. 04, 2016 (GLOBE NEWSWIRE) — Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular... Read More →